Aminosalicylates contain the compound 5-aminosalicylic acid, or 5-ASA, which helps reduce inflammation. These drugs are used to prevent relapses and maintain remission in mild-to-moderate Crohns disease.
The standard aminosalicylate drug is sulfazine (Azulfidine). This drug combines the 5-ASA drug mesalamine with sulfapyridine, a sulfa antibiotic. While sulfazine is cheap and effective, the sulfa component of the drug can cause unpleasant side effects,...
Read moreFebruary is American Heart month and should represent a valentine to all of us. Many people think that the only way to contribute to... Read more »
News media sound bites were ricocheting around the Internet last week suggesting that perhaps type 2 diabetes is an intestinal disorder... Read more »
I don’t know about you, but the word “cure” provokes an instantaneous reaction in me of pure revulsion. The left side of my lip... Read more »
Hi everyone. Today, I want to talk about some medical conditions and their treatments in relation to skin cancer. While most people... Read more »
Summertime can be a lot of fun. Who doesn't love sitting out by the pool relaxing with a cold drink? Unfortunately when you have medical... Read more »
A new pill has halted osteoporosis in an animal study, and may offer hope for humans as well, researchers have found. The medication prevents the... Read more »
Source: ADAM Encyclopedia
The American Academy of Sleep Medicine recommends medications for RLS or PLMD only for persons who fit strict diagnostic criteria, and who experience... Read more »
Surgery and medication are viable options for long-term acid reflux sufferers, but experts say neither treatment is perfect. In a 12-year study,... Read more »
Source: ADAM Encyclopedia
Hearing loss - age related; Presbycusis Treatment There is no known cure for age-related hearing loss. Treatment is focused on improving... Read more »
Informative and Educational Migraine and Headache Articles These articles are listed in alphabetical order. You can search the page by hitting the... Read more »